Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLT: Liver Transplantation for Colorectal Cancer Liver Metastases
NCT03803436Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jan 2019
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 2, open-label trial in colorectal cancer (CRC) and liver metastases (2 arms), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoint: Overall Survival at 5 years. Started Jan 2019; status: completed.
02
Conditions
colorectal cancer (CRC)liver metastases
Beyond the preview
Go deeper on NCT03803436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03803436.